{
    "eid": "2-s2.0-85129400903",
    "title": "The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2",
    "cover-date": "2022-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "1,2,3-triazole-containing drug",
        "click reaction",
        "drug discovery",
        "hepatocellular carcinoma (HCC)",
        "selective anti-HepG2 agent",
        "sorafenib analog",
        "targeted cancer drug"
    ],
    "authors": [
        "Sittisak Oekchuae",
        "Jitnapa Sirirak",
        "Purin Charoensuksai",
        "Pawaris Wongprayoon",
        "Natthaya Chuaypen",
        "Jutatip Boonsombat",
        "Somsak Ruchirawat",
        "Pisit Tangkijvanich",
        "Apichart Suksamrarn",
        "Panupun Limpachayaporn"
    ],
    "citedby-count": 3,
    "ref-count": 96,
    "ref-list": [
        "Cancer treatment and survivorship statistics, 2012",
        "Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes",
        "Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines",
        "A combined 3D-QSAR and molecular docking strategy to understand the binding mechanism of V600EB-RAF inhibitors",
        "Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit",
        "Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors",
        "Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer",
        "Chemotherapy and targeted therapy in the management of cervical cancer",
        "From Chemotherapy to Targeted Therapy in Adjuvant Treatment for Stage III Colon Cancer",
        "Targeted cancer therapy",
        "Chemotherapy for Bladder Cancer: Treatment Guidelines for Neoadjuvant Chemotherapy, Bladder Preservation, Adjuvant Chemotherapy, and Metastatic Cancer",
        "Orthotopic models of cancer for preclinical drug evaluation: Advantages and disadvantages",
        "Review of therapeutic drug monitoring of anticancer drugs part two targeted therapies",
        "Large-scale automatic extraction of side effects associated with targeted anticancer drugs from full-text oncological articles",
        "Drug Resistance in Cancer: An Overview",
        "Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs",
        "Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review",
        "Improving Oral Bioavailability of Sorafenib by Optimizing the \u201cSpring\u201d and \u201cParachute\u201d Based on Molecular Interaction Mechanisms",
        "New knowledge of the mechanisms of sorafenib resistance in liver cancer",
        "Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer",
        "Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme",
        "Targeting VEGF/VEGFR to Modulate Antitumor Immunity",
        "The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy",
        "Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents",
        "Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti-and pro-angiogenic therapies",
        "The Adverse Effects of Sorafenib in Patients with Advanced Cancers",
        "The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects",
        "Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors",
        "FDA-approved small-molecule kinase inhibitors",
        "Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity",
        "Role of Raf Kinase in Cancer: Therapeutic Potential of Targeting the Raf/MEK/ERK Signal Transduction Pathway",
        "Raf kinases in cancer-roles and therapeutic opportunities",
        "B-Raf kinase inhibitors for cancer treatment",
        "Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol",
        "Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach",
        "Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents",
        "Synthesis and broad-spectrum antiproliferative activity of diarylamides and diarylureas possessing 1,3,4-oxadiazole derivatives",
        "Design and synthesis of new potent anticancer benzothia-zole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities",
        "The Study of a Novel Sorafenib Derivative HLC-080 as an Antitumor Agent",
        "Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents",
        "Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-RafV600E and VEGFR-2",
        "ChemInform Abstract: 1,2,3-Triazoles in Peptidomimetic Chemistry",
        "The Eighth Central European Conference \u201cChemistry towards Biology\u201d: Snapshot",
        "1,2,3-Triazole-based kojic acid analogs as potent tyrosinase inhibitors: Design, synthesis and biological evaluation",
        "Synthesis and Antitumor Activity of Triazole-Containing Sorafenib Analogs",
        "1,2,3-Triazoles: Scaffold With Medicinal Significance",
        "Design, Synthesis, and Structure-Activity Relationships of 1,2,3-Triazole Benzenesulfonamides as New Selective Leucine-Zipper and Sterile-\u03b1 Motif Kinase (ZAK) Inhibitors",
        "Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents",
        "Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability",
        "Design, synthesis, and biological evaluation of 4-((6,7-dimethoxyquinoline-4-yl)oxy)aniline derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia",
        "Exploring the potential intracellular targets of vascular normalization based on active candidates",
        "Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents",
        "In Silico, Design, and Development: Molecular Modeling towards B-RAF and VEGFR-2 of Novel Sorafenib Derivatives for Targeted Hepatocellular Carcinoma Cancer Inhibitors",
        "Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma",
        "Design, Green Synthesis and Tailoring of Vitamin E TPGS Augmented Niosomal Nano-Carrier of Pyrazolopyrimidines as Potential Anti-Liver and Breast Cancer Agents with Accentuated Oral Bioavailability",
        "Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles",
        "Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors",
        "Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors",
        "Bisphenol-1,2,3-triazole (BPT) Epoxies and Cyanate Esters: Synthesis and Self-Catalyzed Curing",
        "Helical Polycarbodiimide Cloaking of Carbon Nanotubes Enables Inter-Nanotube Exciton Energy Transfer Modulation",
        "Pore surface engineering in covalent organic frameworks",
        "Synthesis and nmR Analysis of 1, 4-Disubstituted 1, 2, 3-Triazoles Tethered to Pyridine, Pyrimidine, and Pyrazine Rings",
        "Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells",
        "1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview",
        "Cytotoxic activity screening of some indigenous Thai plants",
        "Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells",
        "Flavonoid-Enriched Apple Fraction AF4 Induces Cell Cycle Arrest, DNA Topoisomerase II Inhibition, and Apoptosis in Human Liver Cancer HepG2 Cells",
        "Sensitization to oxidative stress and G2/M cell cycle arrest by histone deacetylase inhibition in hepatocellular carcinoma cells",
        "SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules",
        "Lead-and drug-like compounds: The rule-of-five revolution",
        "Medicinal chemical properties of successful central nervous system drugs",
        "Topological Polar Surface Area Defines Substrate Transport by Multidrug Resistance Associated Protein 1 (MRP1/ABCC1)",
        "CuO nanoparticles: Synthesis and application as an efficient reusable catalyst for the preparation of xanthene substituted 1,2,3-triazoles via click chemistry",
        "Click Chemistry Derived Pyridazines: Electron-Deficient Building Blocks with Defined Conformation and Packing Structure",
        "Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors",
        "Design, Synthesis and Anti-Platelet Aggregation Activity Study of Ginkgolide-1,2,3-triazole Derivatives",
        "Transition-Metal-Free Catalytic Synthesis of 1,5-Diaryl-1,2,3-triazoles",
        "Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1\u2013Nrf2 Protein-Protein Interaction",
        "Cyclization of Alkyne-Azide with Isonitrile/CO via Self-Relay Rhodium Catalysis",
        "PdCl2catalyzed efficient assembly of organic azides, CO, and alcohols under mild conditions: A direct approach to synthesize carbamates",
        "Synthesis and Chemiluminescent Activity of Pyridazino[4,5-b]indole-1,4(2H,3H)-diones",
        "Discovery and biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors",
        "A Simple and Effective Synthesis of Aryl Azides via Arenediazonium Tosylates",
        "Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity",
        "In Situ \u201cClick\u201d Assembly of Small Molecule Matrix Metalloprotease Inhibitors Containing Zinc-Chelating Groups",
        "Thermal azide\u2013alkene cycloaddition reactions: Straightfor-ward multi-gram access to \u22062-1,2,3-triazolines in deep eutectic solvents",
        "Synthesis and transformations of 1-(azidophenyl)-1H-tetrazoles",
        "Copper(I)-Catalyzed Synthesis of Azoles. DFT Study Predicts Unprecedented Reactivity and Intermediates",
        "4-(8-quinolylazo)resorcinol and 1-(8-quinolylazo)-2-naphthol: Synthesis and sorption properties",
        "TCFH-NMI: Direct Access to N-Acyl Imidazoliums for Challenging Amide Bond Formations",
        "Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing",
        "Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays",
        "A water-soluble tetrazolium salt useful for colorimetric cell viability assay",
        "Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60018809",
            "affilname": "Silpakorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018809",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60245220",
            "affilname": "Chulabhorn Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60245220",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022676",
            "affilname": "Ramkhamhaeng University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022676",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022464",
            "affilname": "Chulabhorn Royal Academy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022464",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "125194275",
            "affilname": "MHESI",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125194275",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Chemistry, Faculty of Science",
        "THAILAND RESEARCH FUND",
        "Silpakorn University"
    ]
}